Sympathetic overactivity in active ulcerative colitis: effects of clonidine

Area of Science:

• Neurogastroenterology
• Autonomic Neuroscience
• Inflammatory Bowel Disease Research

Background:

• Previous research indicates potential autonomic nervous system dysfunction in inflammatory bowel diseases.
• The specific role of sympathetic nervous system activity in active ulcerative colitis (UC) requires further elucidation.

Purpose of the Study:

• To investigate whether heightened sympathetic activity characterizes active UC.
• To determine if reducing sympathetic activity with clonidine impacts clinical outcomes in UC patients.

Main Methods:

• Assessed autonomic profiles in 23 UC patients and 20 controls using muscle sympathetic nerve activity (MSNA), ECG, blood pressure, and plasma catecholamines.
• Utilized spectral analysis to evaluate cardiac sympathetic (LF(RR)) and parasympathetic (HF(RR)) modulation, and vasomotor control (LF(SAP)).
• Conducted a randomized, placebo-controlled trial of transdermal clonidine in 16 UC patients, comparing autonomic function, disease activity (DAI), and endoscopic findings before and after treatment.

Main Results:

• UC patients exhibited higher resting MSNA, heart rate (HR), LF(RR), LF/HF, and LF(SAP), with lower HF(RR) compared to controls.
• Autonomic responses to head-up tilt were blunted in UC patients.
• Clonidine treatment significantly reduced HR, MSNA, epinephrine, and LF(RR), while increasing HF(RR), unlike placebo.
• Improvements in the autonomic profile correlated with a reduction in DAI scores.

Conclusions:

• Active ulcerative colitis is characterized by an overall increase in sympathetic nervous system activity.
• Pharmacological normalization of the autonomic profile using clonidine was associated with clinical improvement in UC patients.
• These findings highlight the significant role of sympathetic dysregulation in UC pathogenesis and suggest therapeutic potential.